In a historic cohort study of patients hospitalized for COPD exacerbation, we found that patients with cardiac troponin T (cTnT) ≥ 0.04 μg/l had a mortality rate nearly twice as high as patients with no measurable cTnT in the first year after discharge. This evidence concerns the gene TNNT2 and chronic obstructive pulmonary disease.